Applications

1335 – Point of Care Tests to exclude preterm labour: Phosphorylated Insulin-like Growth Factor Binding Protein test

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

New MBS item.

Service or technology in this application

The phIGFBP-1 test can be used to assist physicians to quickly distinguish between:

  • false labour (where there may be contractions and other signs of labour but the woman does not give birth in the next seven days); and
  • true labour (where the woman does give birth in the next seven days).

Identification of false labour can reduce the unnecessary use of therapies such as tocolytics and corticosteroids, both of which have potential side effects, as well as reduce unnecessary hospital admissions.

Type: Investigative

Medical condition this application addresses

The proposed medical service applies to patients presenting with symptoms of pre-term labour. The majority of these women will go onto deliver at term but a significant number are at risk of delivering pre-term which is associated with serious health-risks to the infant.

Meetings to consider this application

  • PASC meeting: 15 August 2013
  • ESC meeting: 8 to 10 October 2014
  • MSAC meeting: 26 to 28 November 2014